A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors

Clinical trial NCT07169734 · RECRUITING

Trial details

NCT number: NCT07169734
Sponsor: Alentis Therapeutics AG
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cervical Squamous Cell Carcinoma Squamous Non-small-cell Lung Cancer Colorectal Cancer Intrahepatic Cholangiocarcinoma Urothelial Carcinoma

Start date: 2025-08-26
Primary completion: 2029-04-05
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.